Entering text into the input field will update the search result below

Medpace - Best Of The Best

Jul. 26, 2020 1:55 PM ETMedpace Holdings, Inc. (MEDP)
Jim Van Meerten profile picture
Jim Van Meerten's Blog
66.09K Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Long Only, Momentum, Portfolio Strategy

Seeking Alpha Analyst Since 2009

Jim Van Meerten writes on financial subjects here and on Barchart Portfolio Blogs and Seeking Alpha. He earned a BS in Accounting and Business Administration from Berry College; a Juris Doctorate from the Woodrow Wilson School of Law; and attended post-baccalaureate and graduate courses in Business Administration, Quantitative Math, and Education at Florida Atlantic University, Georgia State University and University of North Carolina at Charlotte. In the past he has been an accountant, attorney, adjunct professor in Business Law, Accounting and Internal Auditing, financial advisor, supervisory principal, and compliance officer. He also passed the Georgia CPA Exam, the Certified Internal Auditor Exam, and the FINRA Series 7, 24 and 9/10 exams.He is presently also a contributor on MSN Top Stocks Blog, Motley Fool and is a member of the M100 on Marketocracy, an elete honor chosen by the editors of Marketocracy as being in the top 100 portfolio managers of over 100,000 portfoiios they review. He would enjoy hearing your comments at JimVanMeerten@gmail.com.

Summary

  • 100% technical buy signals.
  • 16 new highs and up 20.61% in the last month.
  • 67.50% gain in the last year.

The Barchart Chart of the Day belongs to the medical services company Medpace Holdings (MEDP).  I found the stock by using Barchart's powerful screening tools to find the stocks with the highest Weighted Alpha and technical buy signals, then sorted that list by the most frequent number of new highs in the last month.  I used the Flipchart function to review the charts for consistent price appreciation.  Since the Trend spotter signaled a buy in 6/30 the stock gained 13.75%.

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

MEDP Medpace

Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.

Barchart technical indicators:

  • 100% technical buy signals
  • 64.70+ Weighted Alpha
  • 67.50% gain in the last year
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 16 new highs and up 20.61% in the last month
  • Technical Strength Index 62.89%
  • Technical support level at 104.10
  • Recently traded at 105.81 with a 50 day moving average of 93.34

Fundamental factors:

  • Market Cap $3.79 billion
  • P/E 34.93
  • Revenue expected to grow 24.10% next year
  • Earnings estimated to increase 50.80% next year and continue to compound at an annual rate of 6.00% for the next 5 years
  • Wall Street analysts issued 1 strong buy and 4 hold recommendations on the stock
  • The individual investors following the stock on Motley Fool voted 12 to 2 that the stock will beat the market
  • 2,350 investors are monitoring the stock on Seeking Alpha

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.